AIDS WEEKLY Plus - October 2005Important note: Information in this article was accurate in October 2005. The state of the art may have changed since the publication date.
Click here to return to AIDS WEEKLY PLUS main menu

DonateNow
Print this Article

HIV/AIDS Transmission: Cervicovaginal culture system determines HIV transmission events after exposure

AIDSWEEKLY Plus; Monday, October 24, 2005
Staff Medical Writers


NewsRx -- A cervicovaginal organ culture system was developed to determine HIV transmission events after exposure.

"We have developed human cervicovaginal organ culture systems to examine the initiating events in HIV transmission after exposure to various sources of HIV infectivity, including semen. Newly infected cells were detected in the cervical submucosa 3-4 days after exposure to a primary HIV isolate.

"At earlier times, extensive and stable binding occurred when cervical surfaces were exposed to virions or seminal cells. Cervical mucus provided some protection for the endocervical surface, by physically trapping virions and seminal cells," scientists in the United States report.

"Confocal microscopy combined with 3D surface reconstruction revealed that virions could both bind to the external surface of the cervical epithelium and actually penetrate beneath the epithelial surface.

"In quantitative assays, pretreatment with a blocking antibody directed against 1131 integrin reduced HIV virion binding," wrote D. Maher and colleagues at the University of Minnesota.

Investigators concluded, "Collectively, these results highlight a continuum of complex interactions that occurs when natural sources of HIV infectivity are deposited onto mucosal surfaces in the female reproductive tract."

Maher and colleagues published their study in Proceedings of the National Academy of Sciences of the United States of America (HIV binding, penetration, and primary infection in human cervicovaginal tissue. Proc Natl Acad Sci U S A. 2005 Aug 9;102(32):11504-9.

For additional information, contact P. Southern, University of Minnesota, School of Medicine, Dept. Microbiology, MMC 196, 420 Delaware St. SE, Minneapolis, MN 55455, USA.

The publisher's contact information for the journal Proceedings of the National Academy of Sciences of the United States of America is: National Academy Sciences, 2101 Constitution Avenue NW, Washington, DC 20418, USA.

Keywords: Minneapolis, Minnesota, United States, HIV Transmission, Cervicovaginal Organ Culture System, 3-Dimensional Tissue Surface Reconstruction, Viral Infectivity.

This article was prepared by AIDS Weekly editors from staff and other reports.

Reference

Maher D, Wu X, Schacker T, et al., HIV binding, penetration, and primary infection in human cervicovaginal tissue, Proc Natl Acad Sci U S A. 2005 Aug 9;102(32):11504-9.

PubMED Related articles Search

051024
AW051012


Copyright © 2005 - Charles Henderson, Publisher. All rights Reserved. Permission to reproduce granted to AEGIS by Charles W. Henderson. Authorization to reproduce for personal use granted granted by C. W. Henderson, Publisher, provided that the fee of US$4.50 per copy, per page is paid directly to the Copyright Clearance Center, 27 Congress Street, Salem, Massachusetts 01970, USA. Published by Charles Henderson, Publisher. Editorial & Publishing Office: P.O. Box 5528, Atlanta, GA 30307-0528 / Telephone: (800) 633-4931; Subscription Office: P.O. Box 830409, Birmingham, AL 35283-0409 / FAX: (205) 995-1588 http://www.newsrx.net

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, Bridgestone/Firestone Charitable Trust, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright © 1980,2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.